Lingjun Li, professor in the Pharmaceutical Sciences Division, is the first faculty member to hold the recently created Janis Apinis Professorship. Established by John Apinis and his wife, Inara, in honor of his parents it …
Lingjun Li, professor in the Pharmaceutical Sciences Division, is the first faculty member to hold the recently created Janis Apinis Professorship. Established by John Apinis and his wife, Inara, in honor of his parents it …
Olayinka Shiyanbola, assistant professor in the Social and Administrative Sciences Division, is among the invited presenters for the 8th Patient Adherence and Access Summit to be held in Philadelphia in March.
Evan Rees, a first-year pharmaceutical sciences graduate student in the laboratory of Jason Kwan, assistant professor in the Pharmaceutical Sciences Division, was recently awarded a multiple-year traineeship from the National Institutes of Health (NIH) Biotechnology …
Pharmaceutical Sciences professor Glen Kwon and assistant professors, Jason Kwan and Jiaoyang Jiang are three of seven faculty who submitted applications for the annual Fall Research Competition and selected to receive funding in this round.
Pharmacogenetics and predictive prescribing was the topic addressed by Larisa H. Cavallari, PharmD, BCPS, FCCP, Associate Professor and Associate Chair Department of Pharmacotherapy and Translational Research Director, Center for Pharmacogenomics,
Barry Gidal, professor (CHS) and Chair, Pharmacy Practice Division, presented a plenary session at an international epilepsy conference held in Cuba. Entitled “Advances in the Treatment of Epilepsy: Does Mechanism of Action matter?,” Gidal’s presentation
Glen Kwon, professor, in the Pharmaceutical Sciences Division, has received The American Association of Pharmaceutical Scientists (AAPS) Outstanding Manuscript Award for outstanding achievement in pharmaceutical technologies
Glen Kwon, professor, in the Pharmaceutical Sciences Division, co-founder and chief scientific officer of Co-D Therapeutics, a University of Wisconsin–Madison spinoff, is developing a three-drug cocktail to battle a wide range of cancers.
Orly Vardeny, associate professor (CHS) in the Pharmacy Practice Division, is co-principal investigator for a flu vaccine trial that will test a high dose for heart patients. Vardeny and co-principal investigator Scott Solomon, a cardiologist …
An article authored by Glen Kwon, professor, in the Pharmaceutical Sciences Division, along with Tony Tam, PhD graduate student, and Jieming Gao, post-doctoral researcher, both members of his lab, was published online